Nootropics and Their Effect on Alzheimer
Millions of Americas suffer from Alzheimer and other types of dementia, more than five million of people have Alzheimer and it is a sixth leading cause of death in the United States. One out of three seniors dies due to this disease and it cost the whole nation unimaginable amount of money. And if you have ever encountered with this disease, then you know how serious it can be.
Not any treatment has proven to be effective in curing Alzheimer and dementia so far. It doesn’t show the signs of slowing down, nor it can be stopped. By 2025, it is estimated that a number of people who suffer from this disease and who are 65 or older will come up to an unimaginable figure of seven million. And that is a 40% increase. Scientists need to find a way to cure and prevent the development of this illness. Many of the patients and doctors started to look for additional solutions and nootropics were their first choice. We all know about the benefits of nootropics and their results in improving cognitive functions, but can they prevent dementia and help with a fight regarding Alzheimer, based on numerous studies ? The answer might be yes.
Huperzine A gives small hope in curing this illness. This type of nootropic has been studied for decades as a potential cure. In 1995, a placebo study has been performed, which included 103 persons who suffered from Alzheimer. The research has shown that 60% of patients who were treated with this drug increased their memory, behavioral functions and thinking.
In 2002, this study has been taken to another level. Now the research included 202 individuals who had a diagnosis of possible or probable Alzheimer illness. They were divided into two groups, the first one had been taking Huperzine A for twelve weeks on a daily basis and the other one received a placebo. The group that received regular treatment with Huperzine A showed improvement in mood, behavior, cognition and they had more energy and activity in everyday tasks.
But this is not the only drug that can help treating and preventing Alzheimer and dementia. Vinprocetine is another one that showed results in various studies. A study has been conducted with patients who suffered from a mild case of dementia. 203 individuals were submitted to controlled placebo research. The final result was a high level of use and efficiency of Viprocetine, regarding patients who had moderate organic syndromes.
There are a lot of studies now days that indicate beneficial use of nootropics regarding Alzheimer and dementia, but it is still early to talk about the final result and especially label one as a cure. They surely give us hope that one day will be able to cure this cruel illness and that we shouldn’t be discouraged with the results scientist managed to discover so far. One thing is for sure: if nootropics manage to set up even a small limit in treating this disease, with their development in the future the cure might be in our hands.